These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1427460)
21. The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo. Woodhams BJ; Than T; Than T; Hutton RA Br J Haematol; 1989 Jan; 71(1):107-11. PubMed ID: 2492816 [TBL] [Abstract][Full Text] [Related]
22. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom. Cheng AC; Tsai IH Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090 [TBL] [Abstract][Full Text] [Related]
23. Nerve growth factor from Indian Russell's viper venom (RVV-NGFa) shows high affinity binding to TrkA receptor expressed in breast cancer cells: Application of fluorescence labeled RVV-NGFa in the clinical diagnosis of breast cancer. Islam T; Majumder M; Bidkar A; Ghosh SS; Mukhopadhyay R; Utkin Y; Mukherjee AK Biochimie; 2020 Sep; 176():31-44. PubMed ID: 32585227 [TBL] [Abstract][Full Text] [Related]
24. Crystallization and preliminary X-ray crystallographic analysis of blood coagulation factor V-activating proteinase (RVV-V) from Russell's viper venom. Nakayama D; Ben Ammar Y; Takeda S Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Dec; 65(Pt 12):1306-8. PubMed ID: 20054136 [TBL] [Abstract][Full Text] [Related]
25. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency. Herren T; Straub PW; Haeberli A Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646 [TBL] [Abstract][Full Text] [Related]
26. Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies. Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S Int Immunopharmacol; 2008 Aug; 8(8):1067-73. PubMed ID: 18550009 [TBL] [Abstract][Full Text] [Related]
27. Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies. Yadav PK; Antonyraj CB; Basheer Ahamed SI; Srinivas S PLoS One; 2017; 12(7):e0181216. PubMed ID: 28732041 [TBL] [Abstract][Full Text] [Related]
28. Immunoaffinity chromatographic purification of Russell's viper venom factor X activator using elution in high concentrations of magnesium chloride. Durkee KH; Roh BH; Doellgast GJ Protein Expr Purif; 1993 Oct; 4(5):405-11. PubMed ID: 8251752 [TBL] [Abstract][Full Text] [Related]
29. Russell's viper venom fractions and nephrotoxicity. Swe TN; Kyaw KM; Win H; Win K; Htwe TT Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):657-63. PubMed ID: 9561625 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in RVBCMP. Mukherjee AK Toxicon; 2008 Apr; 51(5):923-33. PubMed ID: 18249434 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic uses of snake venom. Marsh NA Haemostasis; 2001; 31(3-6):211-7. PubMed ID: 11910187 [TBL] [Abstract][Full Text] [Related]
32. Biochemical and pharmacological characterization of a toxic fraction and its cytotoxin-like component isolated from Russell's viper (Daboia russelii russelii) venom. Thakur R; Chattopadhyay P; Mukherjee AK Comp Biochem Physiol C Toxicol Pharmacol; 2015 Feb; 168():55-65. PubMed ID: 25500420 [TBL] [Abstract][Full Text] [Related]
33. New insights into the functions and N-glycan structures of factor X activator from Russell's viper venom. Chen HS; Chen JM; Lin CW; Khoo KH; Tsai IH FEBS J; 2008 Aug; 275(15):3944-58. PubMed ID: 18616470 [TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of a low molecular weight multifunctional cytotoxic phospholipase A2 from Russell's viper venom. Maity G; Mandal S; Chatterjee A; Bhattacharyya D J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(2):232-43. PubMed ID: 16997639 [TBL] [Abstract][Full Text] [Related]
35. Snake venom activators of factor X: an overview. Tans G; Rosing J Haemostasis; 2001; 31(3-6):225-33. PubMed ID: 11910189 [TBL] [Abstract][Full Text] [Related]
36. Neurotoxicity in Russell's viper (Daboia russelii) envenoming in Sri Lanka: a clinical and neurophysiological study. Silva A; Maduwage K; Sedgwick M; Pilapitiya S; Weerawansa P; Dahanayaka NJ; Buckley NA; Siribaddana S; Isbister GK Clin Toxicol (Phila); 2016 Jun; 54(5):411-9. PubMed ID: 26923566 [TBL] [Abstract][Full Text] [Related]
37. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594 [TBL] [Abstract][Full Text] [Related]